Skip to main content
. 2021 Feb 22;10:627572. doi: 10.3389/fonc.2020.627572

Figure 1.

Figure 1

Disease-free survival rate in overall cohort (A) and in subgroups of whether receive SIB-IMRT (B). LPLN regrowth rate in the overall cohort (C) and in subgroups of whether receive SIB-IMRT (D).